AddLife Aandeel

AddLife EBITDA

De EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van AddLife (ALIF B.ST) per 12 aug 2026 bedraagt 993,00 Miljoen SEK. In het voorgaande jaar bedroeg EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) 1,52 Miljard SEK — een verandering van -34,67% (lager).

EBITDA

993,00 MiljoenSEK

YoY

-34,67%

Laatst bijgewerkt:

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van AddLife is 2026 993,00 Miljoen SEK. EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van AddLife was 2025 1,52 Miljard SEK. Het is daarmee -34,67% lager lager dan het jaar ervoor.
Access this data via the Eulerpool API

AddLife Aandelenanalyse

Wat doet AddLife? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife is een van de meest populaire bedrijven op Eulerpool.

Veelgestelde vragen over het aandeel AddLife

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van AddLife bedraagt 993,00 Miljoen SEK in 2026.

EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) van AddLife is veranderd van 1,52 Miljard SEK naar 993,00 Miljoen SEK, wat een verandering van -34,67% vertegenwoordigt. De waarde is lager dan het vorige jaar.

Op Eulerpool vindt u de volledige historische ontwikkeling van EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) AddLife sinds 2006 – met jaarlijkse waarden, grafieken en gedetailleerde analyse.

EBITDA meet de operationele prestaties vóór de impact van de financiële structuur, de belastingomgeving en niet-kasmatige afschrijvingskosten.

EBITDA = EBIT + Afschrijvingen en amortisaties

SEK van EBITDA (Winst voor rente, belastingen, afschrijvingen en amortisaties) is een belangrijke factor voor beleggers. Veranderingen in deze maatstaf kunnen sterke signalen geven voor toekomstige koersontwikkelingen.

Access this data via the Eulerpool API

Winst-en-verliesrekening — AddLife

Alle kengetallen — AddLife